PT3643717T - Compostos de pirrolo triazina substituídos na posição 7 ou sais farmaceuticamente aceitáveis dos mesmos e método de preparação dos mesmos e utilizações dos mesmos - Google Patents
Compostos de pirrolo triazina substituídos na posição 7 ou sais farmaceuticamente aceitáveis dos mesmos e método de preparação dos mesmos e utilizações dos mesmosInfo
- Publication number
- PT3643717T PT3643717T PT188206155T PT18820615T PT3643717T PT 3643717 T PT3643717 T PT 3643717T PT 188206155 T PT188206155 T PT 188206155T PT 18820615 T PT18820615 T PT 18820615T PT 3643717 T PT3643717 T PT 3643717T
- Authority
- PT
- Portugal
- Prior art keywords
- preparation
- pharmaceutically acceptable
- acceptable salts
- method therefor
- triazine compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710493411.2A CN109111447A (zh) | 2017-06-23 | 2017-06-23 | 7-位取代吡咯并三嗪类化合物或其药学上可用的盐，及其制备方法和用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3643717T true PT3643717T (pt) | 2021-08-31 |
Family
ID=64733772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT188206155T PT3643717T (pt) | 2017-06-23 | 2018-06-22 | Compostos de pirrolo triazina substituídos na posição 7 ou sais farmaceuticamente aceitáveis dos mesmos e método de preparação dos mesmos e utilizações dos mesmos |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11214572B2 (pt) |
| EP (1) | EP3643717B1 (pt) |
| JP (1) | JP6852199B2 (pt) |
| KR (1) | KR102413943B1 (pt) |
| CN (2) | CN109111447A (pt) |
| AU (1) | AU2018287971B9 (pt) |
| BR (1) | BR112019027545A2 (pt) |
| CA (1) | CA3068114C (pt) |
| ES (1) | ES2887629T3 (pt) |
| PT (1) | PT3643717T (pt) |
| RU (1) | RU2745548C1 (pt) |
| SG (1) | SG11201912827TA (pt) |
| WO (1) | WO2018233684A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022003217A (es) * | 2019-09-19 | 2022-06-29 | Totus Medicines Inc | Conjugados terapeuticos. |
| CN111909153B (zh) * | 2020-04-16 | 2021-11-19 | 山东鲁西药业有限公司 | 7-碘吡咯并[2,1-f][1,2,4]三嗪-4-胺的合成工艺 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7932260B2 (en) | 2004-05-13 | 2011-04-26 | Icos Corporation | Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| CA2761445A1 (en) | 2009-05-27 | 2010-12-02 | Genentech, Inc. | Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use |
| KR20140036269A (ko) | 2011-07-01 | 2014-03-25 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | Alk1 억제제로서의 히드록시메틸아릴-치환된 피롤로트리아진 |
| EP2822942B1 (en) | 2012-03-06 | 2017-05-10 | Boehringer Ingelheim International GmbH | Benzodioxanes for inhibiting leukotriene production |
| CN103450204B (zh) | 2012-05-31 | 2016-08-17 | 中国科学院上海药物研究所 | 吡咯[2，1-f][1，2，4]并三嗪类化合物，其制备方法及用途 |
| CN102675323B (zh) | 2012-06-01 | 2014-04-09 | 南京药石药物研发有限公司 | 吡咯并[2,1-f][1,2,4]三嗪衍生物及其抗肿瘤用途 |
| MA37975B2 (fr) | 2012-09-11 | 2021-03-31 | Genzyme Corp | Inhibiteurs de synthase de glucosylcéramide |
| US9745321B2 (en) | 2013-09-30 | 2017-08-29 | Shanghai Yingli Pharmaceutical Co., Ltd | Fused pyrimidine compound, intermediate, preparation method therefor, and composition and application thereof |
| CA3028822C (en) * | 2016-06-25 | 2021-06-22 | Suzhou Kintor Pharmaceuticals, Inc. | Mechanistic target of rapamycin signaling pathway inhibitors and therapeutic applications thereof |
-
2017
- 2017-06-23 CN CN201710493411.2A patent/CN109111447A/zh active Pending
-
2018
- 2018-06-22 US US16/626,254 patent/US11214572B2/en active Active
- 2018-06-22 ES ES18820615T patent/ES2887629T3/es active Active
- 2018-06-22 SG SG11201912827TA patent/SG11201912827TA/en unknown
- 2018-06-22 WO PCT/CN2018/092419 patent/WO2018233684A1/zh unknown
- 2018-06-22 BR BR112019027545-2A patent/BR112019027545A2/pt active Search and Examination
- 2018-06-22 KR KR1020207002152A patent/KR102413943B1/ko active IP Right Grant
- 2018-06-22 RU RU2020101594A patent/RU2745548C1/ru active
- 2018-06-22 AU AU2018287971A patent/AU2018287971B9/en active Active
- 2018-06-22 CA CA3068114A patent/CA3068114C/en active Active
- 2018-06-22 EP EP18820615.5A patent/EP3643717B1/en active Active
- 2018-06-22 CN CN201880042091.1A patent/CN110869371B/zh active Active
- 2018-06-22 JP JP2019571243A patent/JP6852199B2/ja active Active
- 2018-06-22 PT PT188206155T patent/PT3643717T/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN110869371A (zh) | 2020-03-06 |
| KR102413943B1 (ko) | 2022-06-27 |
| CA3068114C (en) | 2022-05-10 |
| JP2020527541A (ja) | 2020-09-10 |
| AU2018287971B2 (en) | 2020-12-24 |
| RU2745548C1 (ru) | 2021-03-26 |
| CA3068114A1 (en) | 2018-12-27 |
| SG11201912827TA (en) | 2020-01-30 |
| AU2018287971A1 (en) | 2020-02-13 |
| EP3643717A4 (en) | 2020-04-29 |
| US20200157110A1 (en) | 2020-05-21 |
| JP6852199B2 (ja) | 2021-03-31 |
| CN109111447A (zh) | 2019-01-01 |
| ES2887629T3 (es) | 2021-12-23 |
| BR112019027545A2 (pt) | 2020-07-07 |
| CN110869371B (zh) | 2022-04-15 |
| AU2018287971B8 (en) | 2021-02-04 |
| US11214572B2 (en) | 2022-01-04 |
| AU2018287971B9 (en) | 2021-02-11 |
| EP3643717A1 (en) | 2020-04-29 |
| WO2018233684A1 (zh) | 2018-12-27 |
| AU2018287971A8 (en) | 2021-02-04 |
| EP3643717B1 (en) | 2021-06-02 |
| KR20200015786A (ko) | 2020-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288104A (en) | Heterocyclic compounds, preparation methods and their use | |
| EP3539963A4 (en) | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE | |
| SG11202106706TA (en) | Heterocyclic compound intermediate, preparation method therefor and application thereof | |
| IL257481B (en) | Substituted quinolone derivatives, or pharmaceutically acceptable salts or stereoisomers thereof, and pharmaceutical compositions and use thereof | |
| EP3503850A4 (en) | HUMERAL HEAD IMPLANT SYSTEM | |
| SI3453707T1 (sl) | Benzazepinski derivati, postopek priprave, farmacevtski sestavek in uporaba le-teh | |
| EP3424928A4 (en) | HETEROCYCLIC NITROGEN COMPOUND, PREPARATION METHOD, INTERMEDIATE, COMPOSITION AND USE | |
| EP3290420A4 (en) | Pyrimidine pyrrole compound, preparation method therefor, pharmaceutical composition, and uses thereof | |
| EP3466943A4 (en) | DIPHENYLAMINOPYRIMIDINE AND TRIAZINE COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| PT3580208T (pt) | Derivados de 2-(3-(1h-benzo[d]imidazol-1-il)propil)piperidin-3-ol e compostos relacionados como inibidores de prs para tratamento de, por exemplo, cancro | |
| EP3705478A4 (en) | TRIAZINE COMPOUND AND PHARMACEUTICAL SALT THEREOF | |
| EP3480198A4 (en) | NEW COMPOUND OR ITS PHARMACEUTICALLY ACCEPTED SALT | |
| SG11202007521PA (en) | Urea-substituted aromatic ring-linked dioxazoline compound, preparation method therefor, and uses thereof | |
| EP3663293A4 (en) | SUBSTITUTED PENTA- AND HEXA-HETEROCYCLIC COMPOUNDS, CORRESPONDING METHOD OF PREPARATION, COMBINATION OF DRUGS AND ASSOCIATED USE | |
| EP3398958A4 (en) | POLYAMIDIC ACID, PROTEIN POLYAMINOIC ACID CONJUGATE AND MANUFACTURING METHOD THEREFOR | |
| ZA201805600B (en) | Pyrimidine seven-membered-ring compounds, preparation method therefor, pharmaceutical composition thereof, and uses thereof | |
| HUE056922T2 (hu) | 2-szubsztituált amino-naft[1,2-D]imidazol-5-on vegyületek vagy azok gyógyszerészetileg elfogadható sói | |
| EP3640248A4 (en) | AMINOPYRIMIDINE COMPOUND, PROCESS FOR PREPARATION AND USE | |
| SG11202007554TA (en) | Dioxazoline compound, preparation method therefor, and uses thereof | |
| PL3315492T3 (pl) | Pochodna pirazolu lub jej farmaceutycznie dopuszczalna sól | |
| HRP20200104T8 (hr) | Novi heterociklični spoj, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto | |
| PL3484855T3 (pl) | Nowy związek benzyloamidowy, sposób jego wytwarzania i środek roztoczobójczy | |
| IL271233A (en) | Quinolinicyclohexylpropanamide-modified compounds and improved methods for their preparation | |
| PT3643717T (pt) | Compostos de pirrolo triazina substituídos na posição 7 ou sais farmaceuticamente aceitáveis dos mesmos e método de preparação dos mesmos e utilizações dos mesmos | |
| ZA201804663B (en) | C-glycoside derivatives having fused phenyl ring or pharmaceutically acceptable salts thereof, method for preparing the same and pharmaceutical composition comprising the same |